share_log

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga ·  Mar 6 05:31

Gainers

  • NKGen Biotech (NASDAQ:NKGN) stock increased by 62.4% to $1.4 during Tuesday's after-market session. The company's market cap stands at $30.6 million.
  • vTv Therapeutics (NASDAQ:VTVT) stock moved upwards by 13.17% to $15.55. The company's market cap stands at $32.4 million.
  • Cerus (NASDAQ:CERS) stock increased by 9.09% to $2.16. The company's market cap stands at $391.3 million. The company's, Q4 earnings came out today.
  • Sophia Genetics (NASDAQ:SOPH) stock increased by 7.32% to $6.01. The company's market cap stands at $391.4 million. The company's, Q4 earnings came out today.
  • YS Biopharma Co (NASDAQ:YS) stock rose 6.36% to $0.65. The market value of their outstanding shares is at $122.1 million.
  • Aldeyra Therapeutics (NASDAQ:ALDX) shares increased by 6.1% to $4.17. The company's market cap stands at $245.2 million.

Losers

  • Heart Test Laboratories (NASDAQ:HSCS) shares decreased by 22.2% to $0.14 during Tuesday's after-market session. The market value of their outstanding shares is at $8.8 million.
  • Marinus Pharma (NASDAQ:MRNS) stock decreased by 12.56% to $8.08. The company's market cap stands at $440.9 million. As per the press release, Q4 earnings came out today.
  • Compass Therapeutics (NASDAQ:CMPX) shares declined by 10.39% to $1.64. The company's market cap stands at $209.0 million.
  • Cara Therapeutics (NASDAQ:CARA) shares decreased by 8.8% to $0.83. The market value of their outstanding shares is at $45.2 million. The company's, Q4 earnings came out yesterday.
  • CareMax (NASDAQ:CMAX) stock fell 8.42% to $10.89. The company's market cap stands at $40.7 million.
  • Envoy Medical (NASDAQ:COCH) shares fell 8.01% to $8.5. The market value of their outstanding shares is at $166.1 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment